Navigation Links
Leading Dental Stem Cell and Regenerative Medicine Researcher Dr. George Huang Joins StemSave's Science Advisory Council
Date:1/18/2011

NEW YORK, Jan. 18, 2011 /PRNewswire/ -- StemSave, the market leader in the field of dental stem cell recovery and cryo-preservation, today announced Dr. George T.-J. Huang, DDS, MSD, DSc, the Chair and Herbert Schilder Professor in Endodontics and Director of the Postgraduate Program in Endodontics of Boston University's Henry M. Goldman School of Dental Medicine, joined its Science Advisory Council.  Dr. Huang will support and advise StemSave as it continues to expand its easy-to-use stem cell banking technology that lets people store stem cells collected from their own teeth as part of a routine visit to the dentist's office.

"Dr. Huang is a preeminent member of the dental stem cell research community and his work around tissue regeneration is changing the way we think about dentistry.  His expertise will play a critical role in our continued growth and we are very fortunate to have him on board," says Art Greco, CEO of StemSave.

Dr. Huang has published more than 100 research articles, review articles, book chapters and abstracts on stem cell development and regenerative medicine.  His research focuses on using dental stem cells to advance regenerative medicine, in particular the use of dental stem cells to create iPS cell lines as well as the regeneration of dental tissues such as dental pulp, dentin and periodontal ligament.

"Stem cell based tissue regeneration is going to play an increasingly more vital role in the medical health and treatments of people today.  StemSave understands that to take full advantage of these medical breakthroughs, people need an easy way to bank their stem cells at any time in life – and it doesn't get easier than a routine trip to the dentist's office," says Dr. Huang.  

Dr. Huang joins Dr. Jeremy J. Mao, DDS, PhD; Gordana Vunjak-Novakovic, PhD; and David A Matzilevich, MD, PhD on the StemSave advisory council.

StemSave, Inc.

StemSave provides an affordable and non-invasive method for the recovery and cryo-preservation of the powerful Adult Stem Cells found in teeth by teaming up with dentists to harvest stem cells during routine dental procedures. For more information, visit www.StemSave.com.


'/>"/>
SOURCE StemSave, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):